Skip to content

← All news

Markets

UBS reiterates Buy on Summit Therapeutics stock, $33 target

1 source ·2 articles ·Sep 9, 13:20 UTC UBS Summit Therapeutics

Covered by 1 outlet

All coverage · 2 articles

Investing.com Stock Market ·Sep 9, 13:20 UTC

Summit Therapeutics stock surges on Jefferies upgrade to buy

Investing.com News ·Sep 8, 13:58 UTC

UBS reiterates Buy on Summit Therapeutics stock, $33 target